A systematic overview of chemotherapy effects in ovarian cancer.
about
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerTherapeutic efficacy of nanomedicines for prostate cancer: An updateFirst-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study.A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancerDiagnosis and treatment of sarcoma of the uterus. A review.The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in ChicagoNoscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients.18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins.Guanylate cyclase activator YC-1 enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells via activation of apoptosis-related proteins.Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway.Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer.Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback.Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.Biocompatible poly(N-isopropylacrylamide)-g-carboxymethyl chitosan hydrogels as carriers for sustained release of cisplatin
P2860
Q24240177-754B245D-8C74-4342-A21E-1AC5A1CEC046Q26766305-4B338D25-999C-45F4-9B4D-9C6CE6EF8D14Q33373163-87BC1684-F7A8-4112-89B2-4EECA5A2D8D4Q33584346-B6930C52-4FE6-474B-A492-542073C54838Q34336818-E674149F-22BC-4E80-97F4-453E50BDC904Q35647075-741360EA-EACC-4841-9289-0AE4BBC1C776Q38928436-82A1BF32-D0F1-450E-AED5-D8E411C6B843Q39249608-5CB7D7AA-2276-4B0F-B1B9-757271CE1DAFQ39302074-EF5148A9-8BCC-4F92-BB63-5BF746E88E7BQ39498655-46FA2560-D300-430C-9B04-D04E46D41ECCQ39545932-65AB7A97-8209-4084-BB37-F644F90BC627Q39625477-EAEDE280-8634-4FCC-B427-53D9C8E9FE3DQ40370693-D76BB530-01DC-4291-8460-F5FFE49D298BQ40591991-F9F02B4F-919A-439C-9C6D-00E36C297A29Q43655173-B560C802-66A9-4BFB-B674-64DA15AD91C5Q44624270-ABB9B7D3-F868-45FD-BBD3-47B732470A4FQ53249660-994F5385-93E3-440F-A5E3-CD47DA78A402Q57347438-CB7CA640-393A-439B-9323-4B6DF5C9F86E
P2860
A systematic overview of chemotherapy effects in ovarian cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A systematic overview of chemotherapy effects in ovarian cancer.
@ast
A systematic overview of chemotherapy effects in ovarian cancer.
@en
A systematic overview of chemotherapy effects in ovarian cancer.
@nl
type
label
A systematic overview of chemotherapy effects in ovarian cancer.
@ast
A systematic overview of chemotherapy effects in ovarian cancer.
@en
A systematic overview of chemotherapy effects in ovarian cancer.
@nl
prefLabel
A systematic overview of chemotherapy effects in ovarian cancer.
@ast
A systematic overview of chemotherapy effects in ovarian cancer.
@en
A systematic overview of chemotherapy effects in ovarian cancer.
@nl
P1433
P1476
A systematic overview of chemotherapy effects in ovarian cancer.
@en
P2093
SBU-group. Swedish Council of Technology Assessment in Health Care
P304
P356
10.1080/02841860151116420
P577
2001-01-01T00:00:00Z